Cargando…

Comparative effectiveness of radiotherapy for early‐stage hormone receptor‐positive breast cancer in elderly women using real‐world data

BACKGROUND: Radiotherapy is the recommended treatment after breast‐conserving surgery (BCS) for early‐stage breast cancer (BC). However, there is no clear evidence whether radiotherapy after BCS improves the survival of elderly women diagnosed with early‐stage hormone receptor‐positive (HR+) BC. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ali, Askal A., Tawk, Rima, Xiao, Hong, Campbell, Ellen, Semykina, Anastasia, Montero, Alberto J., Mogos, Muluberhan, Diaby, Vakaramoko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346228/ https://www.ncbi.nlm.nih.gov/pubmed/30548840 http://dx.doi.org/10.1002/cam4.1904

Ejemplares similares

Real-World Clinical and Economic Outcomes Associated with Palbociclib for HR-Positive/HER2 Negative Metastatic Breast Cancer: A Commentary
por: Babcock, Aram, et al.
Publicado: (2020)

Value Assessment Frameworks in the United States: A Call for Patient Engagement
por: Diaby, Vakaramoko, et al.
Publicado: (2018)

Incorporating health equity into value assessment: frameworks, promising alternatives, and future directions
por: Diaby, Vakaramoko, et al.
Publicado: (2021)

Development and validation of a tool to predict high-need, high-cost patients hospitalised with ischaemic heart disease
por: Nkemdirim Okere, Arinze, et al.
Publicado: (2023)

Application of Machine Learning Algorithms to Predict Uncontrolled Diabetes Using the All of Us Research Program Data
por: Abegaz, Tadesse M., et al.
Publicado: (2023)

Cost-Effectiveness Analysis of Adjuvant Neratinib Following Trastuzumab in Early-Stage HER2-Positive Breast Cancer
por: Tran, Phuong T., et al.
Publicado: (2020)

An Evaluation of the Cost-effectiveness of Comprehensive MTM Integrated with Point-of-Care Phenotypic and Genetic Testing for U.S. Elderly Patients After Percutaneous Coronary Intervention
por: Okere, Arinze Nkemdirim, et al.
Publicado: (2018)

Self-assessed life expectancy among older adults in Côte d’Ivoire
por: Moussa, Richard K., et al.
Publicado: (2020)

Longitudinal Effects of Adjuvant Endocrine Therapy on the Quality of Life of Post-menopausal Women with Non-metastatic ER+ Breast Cancer: A Systematic Review
por: Xiao, Hong, et al.
Publicado: (2018)

Preventing Unnecessary Costs of Drug-Induced Hypoglycemia in Older Adults with Type 2 Diabetes in the United States and Canada
por: Boulin, Mathieu, et al.
Publicado: (2016)

Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases
por: Moyers, Justin T., et al.
Publicado: (2021)

A cost-effectiveness analysis of trastuzumab-containing treatment sequences for HER-2 positive metastatic breast cancer patients in Taiwan
por: Diaby, Vakaramoko, et al.
Publicado: (2019)

Dataset used in the economic evaluation trastuzumab-based regimens for HER-2 positive metastatic breast cancer patients in the Taiwanese healthcare setting
por: Diaby, Vakaramoko, et al.
Publicado: (2020)

Neuregulin modulates hormone receptor levels in breast cancer through concerted action on multiple signaling pathways
por: Almaraz Postigo, Sheila, et al.
Publicado: (2023)

Systemic Therapies Following Progression on First-line CDK4/6-inhibitor Treatment: Analysis of Real-world Data
por: Martin, James M, et al.
Publicado: (2022)

Ultra-hypofractionated whole breast adjuvant radiotherapy in the real-world setting: single experience with 271 elderly/frail patients treated with 3D and IMRT technique
por: Zerella, Maria Alessia, et al.
Publicado: (2022)

A real‐world comparison of docetaxel versus abiraterone acetate for metastatic hormone‐sensitive prostate cancer
por: Tsaur, Igor, et al.
Publicado: (2021)

Risk of cardiovascular disease following gonadotropin‐releasing hormone agonists vs antagonists in prostate cancer: Real‐world evidence from five databases
por: George, Gincy, et al.
Publicado: (2020)

Real-World Evaluation of Disease Progression After CDK 4/6 Inhibitor Therapy in Patients With Hormone Receptor-Positive Metastatic Breast Cancer
por: West, Malinda T, et al.
Publicado: (2023)

The Effect of Radiotherapy on the Concentration of Plasma Lipids in Elderly Prostate Cancer Patients
por: Wolny-Rokicka, Edyta, et al.
Publicado: (2019)

Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real‐world data
por: Jongeneel, Gabrielle, et al.
Publicado: (2019)

Umbilical metastases: Real‐world data shows abysmal outcome
por: Hugen, Niek, et al.
Publicado: (2021)

The concordance of treatment decision guided by OncotypeDX and the PREDICT tool in real‐world early‐stage breast cancer
por: Goldstein, Daniel A., et al.
Publicado: (2020)

Real‐world outcomes of chemoradiotherapy for unresectable Stage III non‐small cell lung cancer: The SOLUTION study
por: Horinouchi, Hidehito, et al.
Publicado: (2020)

Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study
por: Mentrasti, Giulia, et al.
Publicado: (2022)

RSV testing practice and positivity by patient demographics in the United States: integrated analyses of MarketScan and NREVSS databases
por: Tran, Phuong T., et al.
Publicado: (2022)

Real world experience of R‐CHOP with or without consolidative radiotherapy vs DA‐EPOCH‐R in the first‐line treatment of primary mediastinal B‐cell lymphoma
por: Chan, Esther Hian Li, et al.
Publicado: (2019)

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
por: Khalil, Lana, et al.
Publicado: (2022)

ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world Data
por: Moskovitz, Mor, et al.
Publicado: (2022)

Aging‐related prognosis analysis of definitive radiotherapy for very elderly esophageal cancer
por: Zhou, Yong‐Chun, et al.
Publicado: (2018)

Comparative Effectiveness of Palliative Chemotherapy in Metastatic Breast Cancer: A Real‐World Evidence Analysis
por: Feinberg, Bruce, et al.
Publicado: (2020)

Real‐World Adherence in Patients with Metastatic Colorectal Cancer Treated with Trifluridine plus Tipiracil or Regorafenib
por: Patel, Anuj K., et al.
Publicado: (2019)

Real-world Evidence to Estimate Prostate Cancer Costs for First-line Treatment or Active Surveillance
por: Magnani, Christopher J., et al.
Publicado: (2020)

Everolimus-Induced Pneumonitis in Patients with Neuroendocrine Neoplasms: Real-World Study on Risk Factors and Outcomes
por: Taboada, Rodrigo G, et al.
Publicado: (2022)

Health care utilization and costs associated with direct-acting antivirals for patients with substance use disorders and chronic hepatitis C
por: Jiang, Xinyi, et al.
Publicado: (2021)

Recurrent patterns after postoperative radiotherapy for early stage endometrial cancer: A competing risk analysis model
por: Ren, Kang, et al.
Publicado: (2021)

Real‐world outcomes of advanced melanoma patients not represented in phase III trials
por: van Zeijl, Michiel C. T., et al.
Publicado: (2020)

Real-World Evaluation of Modern Adjuvant Radiotherapy in Women with Stage IB Endometrial Cancer
por: Chen, Jenny Ling-Yu, et al.
Publicado: (2021)

A real‐world, population‐based study of patterns of referral, treatment, and outcomes for advanced pancreatic cancer
por: Abdel‐Rahman, Omar, et al.
Publicado: (2018)

Real-world Treatment Patterns and Clinical Outcomes for Metastatic Renal Cell Carcinoma in the Current Treatment Era
por: Shah, Neil J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9dosje5duohu6mq92jmfs78pmb